NO954807L - Terapeutisk anvendelse av hemoglobin ved behandling av blodkarblokkering - Google Patents
Terapeutisk anvendelse av hemoglobin ved behandling av blodkarblokkeringInfo
- Publication number
- NO954807L NO954807L NO954807A NO954807A NO954807L NO 954807 L NO954807 L NO 954807L NO 954807 A NO954807 A NO 954807A NO 954807 A NO954807 A NO 954807A NO 954807 L NO954807 L NO 954807L
- Authority
- NO
- Norway
- Prior art keywords
- hemoglobin
- treatment
- blood vessel
- therapeutic use
- reduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Administrering av lave doser av hemoglobin minimaliserer skade på myo- kardiet etter blokkering og reduserer signifikant reperfusjonsskade. Hemo- globin oppviser en farmakologisk effekt ved å øke perfusJon og blokkere de molekylære virkninger som fører til permanent skade etter en iskemisk episode. Ytterligere fordeler inklu- derer en reduksjon av antallet post- iskemiske arytmier, reduksjon av fore- komsten av restenose og forbedret kontraktil funksjon i risikoområdet.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21853694A | 1994-03-28 | 1994-03-28 | |
US08/350,204 US6458762B1 (en) | 1994-03-28 | 1994-12-02 | Therapeutic use of hemoglobin for preserving tissue viability and reducing restenosis |
PCT/US1995/003788 WO1995026195A1 (en) | 1994-03-28 | 1995-03-27 | Therapeutic use of hemoglobin in the treatment of blood vessel blockage |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954807D0 NO954807D0 (no) | 1995-11-27 |
NO954807L true NO954807L (no) | 1995-11-27 |
Family
ID=26913008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954807A NO954807L (no) | 1994-03-28 | 1995-11-27 | Terapeutisk anvendelse av hemoglobin ved behandling av blodkarblokkering |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0700298B1 (no) |
JP (1) | JPH08511279A (no) |
AT (1) | ATE243040T1 (no) |
AU (1) | AU692249B2 (no) |
CA (1) | CA2163743A1 (no) |
DE (1) | DE69531086T2 (no) |
ES (1) | ES2202355T3 (no) |
NO (1) | NO954807L (no) |
WO (1) | WO1995026195A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5854209A (en) | 1995-03-23 | 1998-12-29 | Biopure Corporation | Method for oxygenating tissue having reduced red blood cell flow |
DK0815138T3 (da) * | 1995-03-23 | 2002-12-23 | Biopure Corp | Stabil polymeriseret hæmoglobin-blod-erstatning |
JPH10501823A (ja) * | 1995-04-10 | 1998-02-17 | バクスター、インターナショナル、インコーポレイテッド | クモ膜下出血の治療における架橋ヘモグロビンの使用 |
WO2006107107A1 (ja) * | 2005-04-01 | 2006-10-12 | Fumitaka Ohsuzu | リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87707A (en) * | 1988-09-08 | 1994-06-24 | Technion Inst For Research And | Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof |
IS4198A (is) * | 1993-08-13 | 1995-02-14 | Somatogen, Inc | Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða |
-
1995
- 1995-03-27 WO PCT/US1995/003788 patent/WO1995026195A1/en active IP Right Grant
- 1995-03-27 ES ES95914896T patent/ES2202355T3/es not_active Expired - Lifetime
- 1995-03-27 AU AU21967/95A patent/AU692249B2/en not_active Ceased
- 1995-03-27 JP JP7525250A patent/JPH08511279A/ja not_active Ceased
- 1995-03-27 CA CA002163743A patent/CA2163743A1/en not_active Abandoned
- 1995-03-27 DE DE69531086T patent/DE69531086T2/de not_active Expired - Fee Related
- 1995-03-27 AT AT95914896T patent/ATE243040T1/de not_active IP Right Cessation
- 1995-03-27 EP EP95914896A patent/EP0700298B1/en not_active Expired - Lifetime
- 1995-11-27 NO NO954807A patent/NO954807L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO954807D0 (no) | 1995-11-27 |
EP0700298A1 (en) | 1996-03-13 |
ATE243040T1 (de) | 2003-07-15 |
CA2163743A1 (en) | 1995-10-05 |
EP0700298B1 (en) | 2003-06-18 |
JPH08511279A (ja) | 1996-11-26 |
DE69531086T2 (de) | 2004-04-01 |
ES2202355T3 (es) | 2004-04-01 |
DE69531086D1 (de) | 2003-07-24 |
WO1995026195A1 (en) | 1995-10-05 |
AU2196795A (en) | 1995-10-17 |
AU692249B2 (en) | 1998-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2111836A1 (en) | Spin-trapping pharmaceutical compositions and methods for use thereof | |
ATE144704T1 (de) | Mittel zur topischen verabreichung von arzneiwirkstoffen | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
FI922325A0 (fi) | Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar. | |
FR2621818B1 (fr) | Medicament comprenant l'association de polymixine b, de netilmicine et d'amphotericine b administre par vaporisation | |
NO954807D0 (no) | Terapeutisk anvendelse av hemoglobin ved behandling av blodkarblokkering | |
EP1304108A3 (en) | Anti-arrhythmic composition and methods of treatment | |
CA2045605A1 (en) | Treatment of leukocyte dysfunction with gm-csf | |
CA2091134A1 (en) | Therapeutic agent for threatened abortion | |
SE8804640D0 (sv) | Medicament comprising cyclolinopeptide a | |
KR970704442A (ko) | 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia) | |
ATE193451T1 (de) | Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen | |
EA199800770A1 (ru) | Лекарственный препарат для терапевтического лечения вирусного гепатита | |
王有根 | Aspirin and Heart-attack (2) | |
DE69724228D1 (de) | Kombinationstherapie von topoisomerase ii toxinen und bis-dioxypiperazinderivaten | |
BR9811402A (pt) | Uso topicamente ou em outro modo administrado, de endipalene em qualquer concentração e em qualquer solvente | |
DE60125377D1 (de) | Behandlung von hepatitis c mit thymosin, interferon und ribavirin | |
袁兆庄 et al. | STUDIES ON TABELLAE INDIGO NATURALIS IN TREATMENT OF PSORIASIS | |
RU99122488A (ru) | Способ лечения рака эндометрия | |
Pratesi et al. | Eledoisin and bradykinin—Differences in the effects of bradykinin and eledoisin on circulation in skeletal muscles and skin in man | |
SE8903117D0 (sv) | Laekemedel omfattande antamanid | |
TakayukiOhtsubo et al. | ENDOSCOPIC POLYPECTOMY FOR PACEMAKER PATIENTS | |
张鹰 et al. | CHINESE MEDICINAL THERAPY FOR POSTBURN RESIDUAL ULCER—CLINICAL OBSERVATION ON 48 HEALED CASES | |
陈宝兴 et al. | THE USE OF “THYROID PILL” IN THE TREATMENT OF BENIGN NODULES OF THE THYROID——CLINICAL OBSERVATION AND EXPERIMENTAL STUDY | |
杨荫昌 et al. | POINT INJECTION COMBINED WITH ELECTRO-ACUPUNCTURE IN TREATMENT OF 300 CASES OF FACIAL PARALYSIS PERIPHERICA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |